Trials / Completed
CompletedNCT01298648
Special Investigation in Patients With Crohn's Disease (All Patients Investigation)
Special Investigation (All Cases Investigation in Patients With Crohn's Disease)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,716 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- 16 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted to assess adverse drug reactions, incidence of adverse events, and factors that may affect the safety and effectiveness of Humira for the treatment of Crohn's disease.
Conditions
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2011-02-18
- Last updated
- 2018-07-02
- Results posted
- 2014-03-18
Locations
1,131 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01298648. Inclusion in this directory is not an endorsement.